Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STEL
2026
DELISTED
Stellar Bancorp
STEL
| $266K | ﹤0.01% |
+9,039
| New | +$280K |
|
2027
Semtech
SMTC
$11.2B
| $265K | ﹤0.01% |
9,251
| – | – |
|
|
NVRO
2028
DELISTED
NEVRO CORP.
NVRO
| $265K | ﹤0.01% |
6,691
| – | – |
|
|
AVNS
2029
DELISTED
Avanos Medical
AVNS
| $264K | ﹤0.01% |
9,736
| – | – |
|
2030
Digital Turbine
APPS
$986M
| $263K | ﹤0.01% |
17,288
-17,290
| -50% | -$266K |
|
2031
Universal Corp
UVV
$1.32B
| $263K | ﹤0.01% |
4,975
| – | – |
|
|
SMLR
2032
DELISTED
Semler Scientific
SMLR
| $262K | ﹤0.01% |
7,935
-621
| -7% | -$21.5K |
|
|
KDNY
2033
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $262K | ﹤0.01% |
+9,988
| New | +$221K |
|
2034
Center Bancorp
CNOB
$1.65B
| $262K | ﹤0.01% |
10,805
-10,911
| -50% | -$268K |
|
2035
National Bank Holdings
NBHC
$1.92B
| $262K | ﹤0.01% |
6,217
+1
| +0% | +$43 |
|
|
UNIT
2036
Uniti Group
UNIT
$2.36B
| $261K | ﹤0.01% |
47,300
-47,308
| -50% | -$325K |
|
|
MODN
2037
DELISTED
MODEL N, INC.
MODN
| $261K | ﹤0.01% |
6,430
| – | – |
|
2038
Harmonic Inc
HLIT
$1.26B
| $260K | ﹤0.01% |
19,885
-19,885
| -50% | -$277K |
|
2039
OceanFirst Financial
OCFC
$1.68B
| $260K | ﹤0.01% |
12,251
-12,251
| -50% | -$267K |
|
2040
Kratos Defense & Security Solutions
KTOS
$8.68B
| $259K | ﹤0.01% |
25,077
-25,077
| -50% | -$249K |
|
|
CIM
2041
Chimera Investment
CIM
$1.03B
| $257K | ﹤0.01% |
15,619
-15,620
| -50% | -$291K |
|
2042
Newmark Group
NMRK
$2.66B
| $257K | ﹤0.01% |
32,224
-32,228
| -50% | -$269K |
|
|
OPLN
2043
Openlane
OPLN
$4.24B
| $257K | ﹤0.01% |
19,685
-19,689
| -50% | -$264K |
|
2044
MillerKnoll
MLKN
$1.53B
| $257K | ﹤0.01% |
12,218
-12,216
| -50% | -$244K |
|
|
GTY
2045
Getty Realty Corp
GTY
$2.1B
| $256K | ﹤0.01% |
7,574
| – | – |
|
2046
St. Joe Company
JOE
$3.49B
| $256K | ﹤0.01% |
6,608
| – | – |
|
2047
DigitalOcean
DOCN
$14B
| $255K | ﹤0.01% |
10,026
-10,026
| -50% | -$314K |
|
2048
Huron Consulting
HURN
$2.43B
| $255K | ﹤0.01% |
3,513
| – | – |
|
2049
Hope Bancorp
HOPE
$1.79B
| $255K | ﹤0.01% |
19,906
-19,910
| -50% | -$264K |
|
|
RVNC
2050
DELISTED
Revance Therapeutics, Inc.
RVNC
| $255K | ﹤0.01% |
13,795
-33,795
| -71% | -$773K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.